Pharmacology of Serotonin Uptake Inhibitors: Focus on Fluvoxamine
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Glazova N, Merchieva S, Volodina M, Sebentsova E, Manchenko D, Kudrun V Acta Naturae. 2014; 6(3):98-105.
PMID: 25349718 PMC: 4207564.
References
1.
Hrdina P, Foy B, Hepner A, Summers R
. Antidepressant binding sites in brain: autoradiographic comparison of [3H]paroxetine and [3H]imipramine localization and relationship to serotonin transporter. J Pharmacol Exp Ther. 1990; 252(1):410-8.
View
2.
Yates M, Leake A, Candy J, Fairbairn A, McKeith I, Ferrier I
. 5HT2 receptor changes in major depression. Biol Psychiatry. 1990; 27(5):489-96.
DOI: 10.1016/0006-3223(90)90440-d.
View
3.
Nathan R, Perel J, Pollock B, Kupfer D
. The role of neuropharmacologic selectivity in antidepressant action: fluvoxamine versus desipramine. J Clin Psychiatry. 1990; 51(9):367-72.
View
4.
Coppen A, Shaw D, Farrell J
. Potentiation of the antidepressive effect of a monoamine-oxidase inhibitor by tryptophan. Lancet. 1963; 1(7272):79-81.
DOI: 10.1016/s0140-6736(63)91084-5.
View
5.
Sulser F
. Deamplification of noradrenergic signal transfer by antidepressants: a unified catecholamine-serotonin hypothesis of affective disorders. Psychopharmacol Bull. 1983; 19(3):300-4.
View